Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank100
3Y CAGR+89.1%
5Y CAGR+204.0%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+89.1%/yr
vs +58.8%/yr prior
5Y CAGR
+204.0%/yr
Recent deceleration
Acceleration
+30.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
259.6x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$14.28M+7.4%
2024$13.29M+3.0%
2023$12.90M+511.4%
2022$2.11M+1141.2%
2021$170000.00+209.1%
2020$55000.00-95.4%
2019$1.20M+262.7%
2018$332000.00-